Mental health and illness

Applied filters

If antidepressant-induced hyponatraemia has been diagnosed, how should the depression be treated?

10 June 2019This Medicines Q&A evaluates the evidence available on the management of depression in patients with antidepressant-induced hyponatraemia. Summary Most antidepressants are associated with hyponatraemia, with…

MUSN Monthly Webinar – Mental Health Transfer of Care – Caroline Dada, Leeds & York Partnerships NHS FT

12 June 2019Caroline Dada is Medication Safety Officer and Lead Pharmacist for Specialist/Community Mental Health Services, Gender Identity and STOMP Leeds & York Partnerships NHS Foundation Trust. …


13 April 2019dm+d: Unassigned

A pharmacist lead service for assessment and management of cardiometabolic risk and metabolic syndrome in individuals with severe mental illness (SMI) using an electronic register.

12 April 2019The Leicestershire Physical Health Register has been developed by the pharmacy mental health team in Leicestershire Partnership NHS Trust. The register helps clinicians/teams ensure patients…

Triptans and SSRI or SNRI antidepressants – is there an interaction?

27 March 2019The likelihood of an interaction between triptans and SSRIs/SNRIs resulting in serotonin syndrome is considered in this updated Medicines Q&A.

Tamoxifen and SSRI or SNRI antidepressants – is there an interaction?

15 February 2019This updated Medicines Q&A reviews the evidence for an interaction between tamoxifen and selective serotonin reuptake inhibitors (SSRIs)/serotonin noradrenaline reuptake inhibitors (SNRIs) resulting in reduced…


8 January 2019dm+d: Unassigned


2 January 2019dm+d: Unassigned


30 November 2018dm+d: Unassigned

MUSN Monthly Webinar – Anticholinergic Drugs and Dementia

13 December 2018Current NICE guidance on Dementia recommends minimising the use of medicines associated with increased anticholinergic burden and to look for alternatives where possible. So far, identifying…